TSCC: Two-Stage Combinatorial Clustering for virtual screening using protein-ligand interactions and physicochemical features by Clinciu, Daniel L et al.
PROCEEDINGS Open Access
TSCC: Two-Stage Combinatorial Clustering
for virtual screening using protein-ligand
interactions and physicochemical features
Daniel L Clinciu
1,4, Yen-Fu Chen
1, Cheng-Neng Ko
1, Chi-Chun Lo
4, Jinn-Moon Yang
1,2,3*
From Asia Pacific Bioinformatics Network (APBioNet) Ninth International Conference on Bioinformatics
(InCoB2010)
Tokyo, Japan. 26-28 September 2010
Abstract
Background: The increasing numbers of 3D compounds and protein complexes stored in databases contribute
greatly to current advances in biotechnology, being employed in several pharmaceutical and industrial
applications. However, screening and retrieving appropriate candidates as well as handling false positives presents
a challenge for all post-screening analysis methods employed in retrieving therapeutic and industrial targets.
Results: Using the TSCC method, virtually screened compounds were clustered based on their protein-ligand
interactions, followed by structure clustering employing physicochemical features, to retrieve the final compounds.
Based on the protein-ligand interaction profile (first stage), docked compounds can be clustered into groups with
distinct binding interactions. Structure clustering (second stage) grouped similar compounds obtained from the
first stage into clusters of similar structures; the lowest energy compound from each cluster being selected as a
final candidate.
Conclusion: By representing interactions at the atomic-level and including measures of interaction strength, better
descriptions of protein-ligand interactions and a more specific analysis of virtual screening was achieved. The two-
stage clustering approach enhanced our post-screening analysis resulting in accurate performances in clustering,
mining and visualizing compound candidates, thus, improving virtual screening enrichment.
Background
Continuous advancements in high-throughput X-ray
crystallography and genomics [1,2] account for numer-
ous available three-dimensional (3D) structures, enabling
the development of new potential therapeutic and
industrial targets. However, prospective ligands and pro-
teins need to be screened in order to downsize groups
[3-7] and select suitable candidates for post-screening
analysis. Clustering methods based on structural similar-
ity which are employed in post-screening analysis gener-
ally improve the scoring function performance. In
developing methods for 3D compound retrieval, a
detailed understanding of intermolecular interactions
between proteins and their ligands is critical to struc-
ture-based inhibitor design. Various post-screening ana-
lysis methods clustering and [8-13] employ the root
mean square deviation (RMSD), protein-ligand interac-
tions and computation and comparison platforms for
measuring distances. Since the above methods as well as
TSCC encounter challenges of specific selectivity and
false positives, we aim to provide advantages of our
cluster analysis method to to enrich accuracy and effec-
tively mine candidates for bioassay.
One of the above methods, a post-screening analysis
for visualizing protein-ligand interaction (VISCANA)
which analyzes the receptor and ligand pattern of inter-
action on the basis of quantum theory is an approach
proposed by Amari et al [12]. VISCANA applies the ab
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represent the interaction between a protein and its
ligand. The FMO method has an advantage of describ-
ing the charge-transfer between a receptor and a ligand
in comparison to a conventional force field method
using fixed atomic charges. However, it lacks sufficient
descriptions of van der Waals forces and hydrogen bond
interactions which play an important role in receptor-
ligand binding and this may account for additional false
positives.
Another method is NIPALSTREE, an approach by
Bocker et al [13] for clustering large datasets in high
dimensional space. It uses the first Principal Component
which employs NIPALS (non-linear iterative least
squares) where the data set is split at point i or j (deter-
mined points where two neighbors exceed a predefined
distance threshold T). Calibur [7] is a new tool designed
for clustering very large numbers of protein decoys in
ab initio protein structure prediction. Since various
post-screening analysis methods deal with increasing
number of decoys, it can be a useful tool as it can per-
form the clustering in one third of the time required if
its strategies are not used.
Our goal is to develop a cluster analysis for protein-
ligand complexes using protein-ligand molecular inter-
actions. We employed the empirical energy function
from GEMDOCK [15] and the basic premise of SIFt
[16] to encode additional interaction-specific informa-
tion into the real number strings, hydrogen bonds, van
der Waal and electrostatic forces. By representing inter-
actions at the atomic-level as opposed to the residue
level and including measures of interactions strength,
protein-ligand interactions can be described better and a
more precise analysis of virtual screening can be
obtained.
TSCC is accomplished by the joining of two clustering
stages; one of protein-ligand interactions (e.g. hydrogen
bonds, electrostatic interactions, and van der Waals
forces) with another of physicochemical features per-
formed on compounds selected through the first stage
of clustering. We employed our docking tool, GEM-
DOCK, to generate protein-ligand interactions and used
the Accelrys Cerius QSAR module for obtaining physi-
cochemical features of complexes. Based on normalized
feature profiles, hierarchical and K-mean [17] clustering
methods were used to cluster compound candidates.
Since clustering based upon similarity requires a quanti-
tative measure (descriptor) of the similarity between two
molecules, 2D and 3D methods were used to generate a
descriptor such as the atom pair descriptor (i.e. com-
pound topological similarity) [18].
A cluster analysis for selecting candidates from a large
number of database compounds requires prior screening
techniques which must employ docking and screening
tools. To handle the vast results from virtual screening
and use more specific information for protein-ligand bind-
ing, we utilize the empirical energy function from GEM-
DOCK specifically optimized for virtual screening.
GEMDOCK used piecewise linear potential (PLP) that is a
simple scoring function and is comparable to some scor-
ing functions for estimating binding affinities [19-21]. Our
previous works showed that GEMDOCK was compared to
some docking methods on the 100 protein-ligand com-
plexes and two virtual screening targets [4,22]. In addition,
GEMDOCK has been successfully applied to identify inhi-
bitors and binding sites for some targets [23-27]. Here, we
currently utilized the PLP of GEMDOCK to generate the
protein-ligand interaction profiles.
To demonstrate the efficiency of our method we suc-
cessfully applied its combinatorial two-stage concept on
five common targets by constructing two compound
sets to screen against each target protein. The first com-
pound set, a verifying dataset, was used to determine if
the protein-ligand interaction descriptor is suitable for
identifying compounds with similar binding modes. The
second compound set, a testing dataset, was used to
evaluate the database enrichment potential and the
property of compounds in the same cluster by docking
a diverse set of compounds spiked with known inhibi-
tors into the same target protein as shown below.
Methods
The Two-Stage Combinatorial Clustering (TSCC)
methodology
The overview of our method is shown in Figure1. We
first calculated the atom-basedprotein-ligand interac-
tions by converting every docked pose into a one
dimensional real number string in order to visualize and
analyze large data obtained from virtual screening using
Yang et al [22]. Due to protein-ligand interactions
representation, we were able to evaluate the distance of
binding modes between two docked poses and to carry
out hierarchical clustering analysis. Compounds with a
similar binding mode were visualized and grouped into
clusters [28]. In our structure based clustering section,
each structure was represented by a one dimension
atom-pair descriptor, an approach proposed by Carhart
et al [18]. After analyzing the distance between active
and non-active compounds, a reference threshold was
decided for demarcating similar compounds (Fig.2).
We generated two sets of structure-based virtual
screening results: 1) to verify if the protein-ligand inter-
action descriptor is suitable for identifying compounds
with similar binding mode and 2) to evaluate the data-
base enrichment potential and the property of com-
pounds in the same cluster by docking a diverse set of
compounds spiked with known inhibitors into the same
target protein.
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We tested the virtual screening results against the five
target proteins: 1) herpes simplex virus type 1 thymidine
kinase (TK) [29] PDB identification (ID): lkim, 2)
human estrogen receptor alpha (ERa) [22,30] PDB ID:
3ert, 3) human estrogen receptor alpha (ERa)P D BI D :
lgwr, 4) human dihydrofolate reductase (hDHFR) [31,32]
PDB ID: lhfr, and 5) tern n9 influenza virus neuramini-
dase (NA) [33,34] PDB ID: lmwe.
The ligand binding site was defined as a collection of
amino acids using a cutoff radius of 10Å from each atom
on the bound ligand, since most studies in lead discovery
use a cutoff radius between 8 to 12 Å. Structure files were
stored as a PDB format for GEMDOCK input and analysis.
Compound databases
We constructed two compound sets for screening against
each target protein. The compound sets for NA of influ-
enza virus were derived from the Comprehensive Medical
Chemistry database (CMC) and only those with molecular
weights between 200 and 800 were chosen. All active com-
pounds (61 total) were listed as the following: 1) TK: 10, 2)
ERa antagonists: 11, 3) ERa agonists: 10, 4) hDHFR: 10,
and 5) NA: 20. The two crystal structures of human estro-
gen receptors alpha have been intensively studied for their
different functions (agonist 1GWR promotes coactivator
binding while antagonist 3ERT blocks it) and ability to
bind on the same site of the protein. The agonists play an
important role in regulation of gene expression and pre-
vention of osteoporosis while the antagonists have been
used as treatment of hormone-dependent breast cancer
[22,30].
The tested dataset contained 990 randomly selected
compounds combined with known active compounds
for each target protein using a method from Bissantz
et al [35]. The 990 compounds is a small scale public
set of compounds used by various studies to test meth-
ods of lead discovery. All compound structures were
converted to mol formats and their hydrogen atoms
removed using CORINA3.0 for GEMDOCK input and
VS. The active compound set of each target protein, tar-
get proteins, and 990 random compounds are available
on the Web at http://gemdock.life.nctu.edu.tw/dock/
download.php.
Figure 1 Overall process of the Two-Stage Combinatorial Cluster Analysis. (a) First stage clustering using protein-ligand interactions
generated via GEMDOCK. (b) Second stage clustering of first stage results done using physicochemical features.
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GEMDOCK was substantially modified, in preparation
for docked poses and to predict the binding affinity for
each compound in the dataset via two key functions: 1)
The searching algorithm and 2) The scoring function
which is based on an empirical energy function (it con-
sists of a simple empirical binding score and a pharma-
cophore-based score with all details of the scoring
function found in Additional File 1).
Testing and Verifying Datasets
The lowest energy conformation was retained for gener-
ating the representative docked pose of each compound.
Generation of Descriptors (Protein-Ligand interaction
descriptors)
We converted 3D docked poses into a one dimension
real number string by calculating the energy between
each atom present on protein and ligand. The interac-
tion energy of each atom j on a protein is defined as:
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Where rij
Bij is the distance between atoms i and j
with interaction type Bij formed by pair-wise heavy
atoms between ligands and proteins, Bij is either a
hydrogen bond or a steric state. These two potentials
are calculated by the same function, although from dif-
ferent parameters; V1,... , V6.q i and qj are the formal
charges and 332.0 is a factor that converts the electro-
static energy into kilocalories per mole. The lig and
pro denote the number of heavy atoms on the ligand.
Fr ij
Bij () is a simple atomic pair-wise potential
function.
Atom pair descriptors
Atom-pair descriptors are 2D topological descriptors
counting the distance between twoatoms as the shortest
path of bonds [18]. The procedure for preparing atom
pair descriptors:
1) Structure files in mol format
2) Remove hydrogen atoms
3) Convert to mol2 format via CORINA3.0
4) Calculate atom pair descriptors via AP generator
(distance bins: 15)
5) Store in binary coding form.
Figure 2 Designing a reference threshold of P-L interaction and atom-pair descriptors. The complementation between atom-pair
descriptor and the protein-ligand interaction descriptor is also show in this figure. The distance threshold of atom-pair descriptor was 0.55
(tanimoto coefficient). The threshold of distance of protein-ligand interaction descriptor was 0.39 (correlation coefficient).
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Page 4 of 12A total of 825 (55 x 15) atom pair descriptors were
generated for each molecular structure by removing all
columns with zero values.
Reference Threshold for Protein-Ligand Interaction and
Atom-Pair Descriptor
To design a reference threshold of protein-ligand inter-
action, a verifying dataset was used in establishing a
reference threshold of distance by determining a maxi-
mum discrimination between similar and non-similar
binding modes. The equation is as follows:
max
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Where t is the reference threshold, Cintra-d<t is the
number of intra active compound pairs with the dis-
tance < threshold and Cinter is the number of compound
pairs between active and non-active compounds.
The Cluster Analysis Method
First, we used a protein-ligand interaction descriptor for
clustering compounds with similar binding modes and
applied the correlation coefficients as similarity mea-
surements. The following formula was used:
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where Dxy
corr is the correlation distance between
docked pose X and Y. Sx is the standard deviation of X.
Xi is the ith value of X. n is the number of descriptors.
We applied the standard UPGMA clustering method for
calculating the distance between two clusters while con-
structing the dendrogram. The formula is defined as:
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The reference threshold was calculated from the veri-
fying dataset using equation (2) to determine the num-
ber of clusters.
Second, we applied the AP descriptor for clustering
compounds within each clustering stage and applied the
tanimoto coefficients as similarity measurements. For-
mula is as follows:
D
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XY
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where Dxy
tani is the tanimoto distance between X and
Y. |X⋂Y| is the number of ON bits common in both X
and Y, and the |X⋃Y| is the number of ON bits present
in either X or Y. This equation is similar to equation
(4); Dxy
corr by Dxy
tani. The dendrogram graph was plotted
for visualizing the binding mode of multi docked poses
by the protein-ligand interactions.
Results
Molecular Recognition
Thymidine kinase
Choosing the crystal coordinates of TK (Fig. S1 in Addi-
tional File 2) in complex with its natural substrate
(deoxythymidine) was reasonable since the active site
can accommodate a broad variety of ligands. The aver-
age RMSD of all ten docked poses was 1.39 Å. (Table 1)
Estrogen receptor a
Table 1 The RMSD values between docked poses and
crystal ligands of 48 compounds for the five targets
TK (lkim) ER (3ert, lgwr) DHFR (lhfr) NA(lmwe)
Complex RMSD Complex RMSD Complex RMSD Complex RMSD
name (Å) name (Å) name (Å) name (Å)
le2k.TMC 0.69 1err.RAL
a 1.27 lboz.PRD 1.13 1l7f_ BCZ 0.88
le2m.HPT 0.51 3ert.
OHT
a
0.71 1dlrMXA 0.62 lnnc_GNA 0.75
le2n.RCA 1.34 1hj1.
AOE
a
3.13 1dls.MTX 1.53 2qwf_G20 0.60
le2p.CCV 0.67 1uom.
PTI
a
0.81 1drf.FOL 1.24 1bji_G21 0.81
1ki2.GA2 3.04 1gwr.
EST
b
0.71 1hfr.MOT 0.51 1f8b_DAN 0.64
lki3.PE2 3.21 112i.ETC
b 0.52 1kms.LIH 1.36 1f8c_4AM 0.46
1ki6.AHU 0.37 1qkm.
GEN
b
2.92 1kmv.LII 0.83 1f8d_9AM 0.59
1ki7.ID2 0.49 3erd.
DES
b
1.32 1mvs.
DTM
0.75 1f8e_49A 0.60
lkim.THM 0.41 1ohj.COP 1.27 1ina_ST6 0.79
2ki5.AC2 3.14 2dhf.DZF 1.12 ling_ST5 1.03
1inw_AXP 0.93
1inx_EQP 0.92
1ivc_ST2 2.09
1ivd_ST1 1.02
1ive_ST3 1.03
Imwe_SIA 0.52
lxoe_ABX 1.33
lxog_ABW 2.42
2qwg_G28 0.80
2qwh_G39 0.74
Average 1.39 Average 1.42 Average 1.03 Average 0.95
aFour antagonists docked into the target protein (3ert)
bFour agonists docked into the target protein (1gwr)
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Page 5 of 12The target protein structures of ERa (Figs. S2 and S3 in
Additional Files 3 and 4) were obtained from PDB,
whereas antagonists and agonists were derived from pre-
vious works. We docked four antagonists into the target
protein (3ert) and four agonists into another one (1gwr),
and concluded their results based on RMSD in the
heavy atoms ligand between the docked pose and the
crystal structure. The average RMSD of docked antago-
nists and agonists was 1.42 Å. The RMSD values of
1hj1.AOE and 1qkm.GEN were larger than 2.0 Å
because the native proteins were crystal structures of ER
a-ligand complexes. (Table 1)
Human dihydrofolate reductase
To evaluate the docking accuracy of GEMDOCK, we
docked 10 known active compounds (Fig. S4 in Addi-
tional File 5) into the target protein and compared the
RMSD values between the docked pose and the bound
ligand in crystal structure. The average RMSD of all ten
docked active compounds was 1.03 Å, substantially
lower than 2 Å, which means GEMDOCK computations
were within the range of accepted accurate values.
Neuraminidase
The 20 known active compounds (Fig. S5 in Additional
File 6 were docked into the target protein and an aver-
age RMSD of 0.95 Å was obtained for all docked poses.
(Table 1)
Significance of protein-ligand interaction descriptor on
the verifying dataset
Significance of known compounds in the five classes
the results are listed in Table 2 using T-scores as the
standard two sample t-test statistics (Additional File 1).
Using equation 2, the maximum discrimination was
determined (Fig. 2) with 88.89% accuracy in distinguish-
ing between similar and non-similar binding modes.
Significance of similar compounds
For the purpose of post-analysis, we tested similar com-
pounds’ docking behavior (pose, interaction) on a pro-
tein receptor. There are five classes of similar
compounds on each target protein. We tested to see
whether the mean distance between similar compounds
represented by protein-ligand interactions is different
than the mean distance between non-similar compounds
(t-test results listed in Table 3).
Significance of an atom pair descriptor
Similar structures were defined as active compounds
and non-similar structures were defined as non-active
compounds (t-test results, Table 4). Active compounds
of hDHFR and NA were divided into two classes
because of their diverse compound structures (Figures
S2 and S3 - Additional Files 3 and 4). The maximum
discrimination between similar and non-similar struc-
tures was determined by distinguishing between similar
and non-similar structures with 91.45% accuracy.
Calculating a reference threshold by verifying dataset
Using a verifying dataset, we calculated the distance
threshold (correlation coefficient: 0.39) that had the
maximum discrimination. The reference threshold of
atom-pair (Tanimoto coefficient: 0.55 in Fig. 2) was cal-
culated via 7 classes of structures showing the comple-
ment between atom-pair descriptor and protein-ligand
interaction descriptor.
Protein-ligand interaction clustering
Cluster analysis of human dihydrofolate reductase
molecular docking
The overlays of all 61 docked poses of known active
compounds in the vicinity of the target protein hDHFR
are shown in Figure 3a. Using the reference threshold of
protein-ligand interaction (correlation coefficient: 0.39),
three major clusters can be identified in Figure 3b, clus-
ters c, d and e. Each cluster has interaction details dis-
played above (e.g. cluster c with fig. c). All active
compounds were grouped together (Fig. 3c). The
hDHFR ligands in cluster c had hydrogen bonds (E30-
OE1, E30-OE2, V115-0, I7-0 in green dotted lines) and
van der Waals forces shown by a blue arc (I60-CAR,
F31-RING) revealing that binding interactions of each
Table 2 T-test of distance between intra-cluster and inter-cluster compound binding modes generated by converting
the docked pose into protein-ligand interaction profile (a=0.01)
Target
protein
H0 Average distance of intra-
cluster compounds (Å)
Average distance of inter-
cluster compounds (Å)
Std
a of distance of intra-
cluster compounds
Std
a of distance of inter-
cluster compounds
p-
value
DHFR Reject 0.21 0.50 0.09 0.13 1.71E-
58
ESA Reject 0.25 0.42 0.13 0.12 7.04E-
20
EST Reject 0.31 0.48 0.09 0.12 7.94E-
39
NA Reject 0.17 0.73 0.07 0.20 0.00E
+00
TK Reject 0.19 0.47 0.08 0.15 3.89E-
64
a Standard Deviation
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Page 6 of 12docked pose within cluster c were similar. Cluster d
contained 6 TK ligands and one NA ligand and cluster
e had only NA ligands, as seen in Figure 3e. Docked
poses within both clusters d and e had hydrogen bond-
ing (V115,I7-0; E30-OE1, V8-N).
When comparing the binding interaction between
clusters in Figures 3c, d, e, f, and g we noted that our
method could cluster docked compound poses into dis-
tinct clusters revealing specific binding interactions and
important protein-ligand interactions.
Table 3 T-test of distance between intra-cluster and inter-cluster compound structures gener-ated by atom-pair
representation (a=0.01)
Target
protein
H0 Average distance of intra-
cluster compounds (Å)
Average distance of inter-
cluster compounds (Å)
Std
a of distance of intra-
cluster compounds
Std
a of distance of inter-
cluster compounds
p-
value
DHFR Reject 0.42 0.63 0.15 0.12 5.84E-
23
ESA Reject 0.24 0.66 0.11 0.14 4.60E-
65
EST Reject 0.27 0.63 0.14 0.14 2.85E-
56
NA Reject 0.32 0.65 0.18 0.17 1.75E-
131
TK Reject 0.22 0.63 0.09 0.19 2.11E-
93
a Standard deviation
Table 4 T-test of distance between intra-cluster and inter-cluster compounds on each target protein. Descriptor was
generated by converting the docked pose into protein-ligand in-teraction profile (a=0.01)
Target
protein
Compound
class
H0 Average distance of intra-
cluster compounds (Å)
Average distance of inter-
cluster compounds (Å)
Std
a of distance of
intra-cluster
compounds
Std
a of distance of
inter-cluster
compounds
p-value
DHFR Reject 0.21 0.50 0.09 0.13 1.71E-58
ESA Reject 0.52 0.58 0.18 0.12 2.73E-03
DHFR EST Reject 0.52 0.63 0.21 0.13 7.51E-07
NA Reject 0.46 0.55 0.13 0.14 5.34E-23
TK Reject 0.38 0.51 0.16 0.13 8.03E-11
DHFR Pass 0.55 0.62 0.28 0.16 0.10111
ESA Reject 0.23 0.48 0.14 0.14 2.29E-31
ESA EST Pass 0.67 0.76 0.25 0.14 0.23105
NA Reject 0.33 0.59 0.24 0.20 1.51E-58
TK Reject 0.46 0.57 0.25 0.20 0.000121
DHFR Pass 0.55 0.57 0.21 0.14 4.01E-01
ESA Reject 0.25 0.42 0.13 0.12 7.04E-20
EST EST Reject 0.31 0.48 0.09 0.12 7.94E-39
NA Reject 0.40 0.46 0.15 0.15 1.46E-09
TK Reject 0.28 0.43 0.09 0.15 2.17E-29
DHFR Reject 0.35 0.68 0.22 0.25 3.46E-25
ESA Reject 0.59 0.71 0.28 0.24 2.91E-04
NA EST Reject 0.56 0.66 0.25 0.24 2.46E-04
NA Reject 0.17 0.73 0.07 0.20 0.00E
+00
TK Reject 0.48 0.60 0.18 0.23 3.46E-07
DHFR Reject 0.42 0.62 0.13 0.10 9.80E-12
ESA Reject 0.16 0.52 0.07 0.13 9.99E-62
TK EST Pass 0.58 0.65 0.18 0.14 6.28E-02
NA Reject 0.40 0.53 0.11 0.15 2.92E-53
TK Reject 0.19 0.47 0.08 0.15 3.89E-64
a Standard Deviation
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Page 7 of 12Figure 3 Cluster analysis of hDHFR. (a) Overlay of all 61 docked poses of known active compounds in the vicinity of the target protein hDHFR
(PDB code: lhfr). (b) The dendrogram and hierarchical clustering results of 61 docked poses of hDHFR. Each cluster has its interaction details in
the figures above (e.g. cluster c in fig c). Docked poses in the heat map are rearranged according to the order given by hierarchical clustering
marked by the black bar ‘c’ in the right side of the heat map. The amino acids identified for description are shown in the top side of the heat
map. (c, d, e) Overlay of the known active compounds and their important interactions, (f, g) Docked poses overlay of the sub-cluster within
hDHFR active compounds. The differences of clusters f and g are shown by blue frames in the heat map.
Clinciu et al. BMC Genomics 2010, 11(Suppl 4):S26
http://www.biomedcentral.com/1471-2164/11/S4/S26
Page 8 of 12Cluster analysis of molecular docking on thymidine kinase
After filtering out clustered compounds, 53 docked
poses were obtained including the 10 docked poses of
active compounds and a total of 305 atoms were identi-
fied here. (Fig. S6 in Additional File 7)
Clustering by atom-pair descriptor
Cluster analysis of compound structures for the verifying
dataset
Observing these three clusters, we deduced the atom-
pair descriptor could group compounds with similar
structures and sorts them from those with different
structures (Fig. 4).
Cluster analysis of virtual screening results on the testing
dataset
Analysis of the hDHFR dataset (first and second stages)
1
st stage: We performed virtual screening for a set of 10
hDHFR inhibitors all spiked into 990 randomly selected
compounds from ACD. A total of 476 involved atoms
were identified in 100 docked poses that include 10
known active compounds. P-L interactions of all com-
plexes were generated, each complex being composed of
316 real numbers. All hDHFR inhibitors were grouped
together into one cluster. In Figure 5a indicated by red
arrows are: F31-stacking forces, 160-van der Waals
forces and NAP-stacking forces. Figures 5b and 5c
shows similar hydrogen bonding (I7-O, V115-O, E30-
OE1, E30-OE2, and N64-ND2) for the target protein
and the 35 unknown compounds, however, the old drug
(Fig. 5c) contains additional hydrogen bonds (R70-NH1,
R70-NH2, and N64-ND2). We also identified and
pointed out important forces on the heat map using red
arrows (I60-van der Waals forces, F31-stacking forces,
F34-stacking forces, NAP-stacking forces) Residues
within old and new drug structures (Fig. 5a and b) are
s h o w ni ny e l l o wa n dt h ed e n d r o g r a mi nF i g u r e3 b
shows the exact split of these two compounds. We uti-
lized 2D topology to select representative compounds
within a cluster after protein-ligand interaction analysis
was performed and representatives were then selected
within each sub-cluster.
2
nd Stage: The cluster contained 45 compounds: 10
active compounds and 35 unknown compounds (Fig.
6a). A one dimension atom-pair binary string of 2D
topology represented each compound. After perform-
ing hierarchical clustering four major clusters were
identified by the dendrogram (Fig. 6b). The active
compounds were spliced into two clusters; the old
drugs (Fig. 6d) and the new drugs (Fig. 6e) due to the
differences in carboxylic acid groups.The sub-struc-
tures within each cluster inside the red circles (Figs. 6c
and f) showed similar compounds within a cluster and
only the lowest energy compound from each cluster
was selected as a final representative (Figs. 6g, h, i and
j). At this stage the selected candidates could be
further verified by bioassays for specific function and
application.
Figure 4 The dendrogram of hierarchical clustering of 61 known compound structures with three major clusters.( a )1 0E R a agonists,
(b) 11 ERa antagonists, (c) 10 TK and 14 NA inhibitors were grouped into one cluster due to their structure similarity. The descriptor was
calculated using the tanimoto coefficient (0.55) via atom-pair representation. It grouped only compounds with similar structures, sorting them
out from those with different structures.
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In search of an improved post-screening analysis for
protein-ligand complexes we developed a combinatorial
cluster analysis aided by two clustering stages to mine
and visualize compound candidates generated by VS.
Five classes of targets and two different data sets were
used to validate this method. In its first clustering stage,
our method encodes more interaction-specific informa-
tion than other methods into the real number string,
hydrogen bond, van der Waal and electrostatic forces
which are important in receptor-ligand binding incre-
asing the efficiency of protein-ligand interaction clus-
tering. Through second-stage clustering, using
physicochemical features as criterion for further screen-
ing, final representatives were retrieved from each clus-
ter containing compounds from first-stage clustering.
Another post-screening analysis method VISCANA,
uses protein-ligand interactions as a means for cluster-
ing but lacks sufficient descriptions of van der Waals
forces and hydrogen bond interactions which play an
important role in receptor-ligand binding. In addition,
its lack of using a specifically optimized docking tool for
protein-ligand interactions during virtual screening may
undermine the accuracy of final representatives as well.
Our goal was to develop a method for selecting ade-
quate representative compounds from a 3D database
that can be used in therapeutic or industrial applica-
tions. Such compounds can be further confirmed
through bioassays to verify our method’s accuracy and
the proper activity and application of these final candi-
dates. This study provides a suggestion of cluster thresh-
old while aiding the retrieval of more specific
representative structures from a large number of virtual
screening data. Furthermore, an overall index criterion
to evaluate the accuracy of our clustering method can
be done in future studies to enable its comparison with
other post-screening analysis methods and thoroughly
investigate screening and retrieving advantages and dis-
advantages of different methods. In future works we
hope to extend our TSCC study into the integration or
conjunction of our TSCC method with Calibur [6] and
NeatMap [3] for the possibility of improving accuracy
and specificity in selecting final representatives.
Conclusions
We showed that by combining interaction clustering
with compound structure clustering an enhanced cluster
analysis is obtained during the retrieval of final
Figure 5 The detail of hDHFR binding interactions of new drugs and old drugs on the verifying dataset. (a) Important forces (red
arrows) on the heat map (160-van der Waals force, F31-stacking force, F34-stacking force, NAP-stacking force); (b), (c) The binding interactions of
new and old drugs and their residues (yellow). The old drug (c) has additional hydrogen bonding with the target protein (Q35, N64, and R70).
Interactions of residues (Q35, N64, and R70) are seen in (b) while (N64 and R70) interactions are seen in (c).
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Page 10 of 12representatives for the five selected targets in this study,
simultaneously improving VS enrichment. The overall
performance of TSCC revealed that sufficient descrip-
tions of protein-ligand interactions are an important
step when mining for ideal protein-ligand complexes.
Although comparison to other cluster analysis methods
can be somewhat ambiguous since different approaches
may vary in goals and purpose, the combination of an
optimized docking tool and two clustering stages for the
scope of selecting ideal representatives revealed promis-
ing results in our study.
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